Genworth Financial, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GNW research report →
Price Chart
About the company
Genworth Financial, Inc. , together with its subsidiaries, provides mortgage and long-term care insurance products in the United States. It operates through two segments: Enact and Closed Block.
- CEO
- Tom McInerney
- IPO
- 2004
- Employees
- 3,100
- HQ
- Glen Allen, VA, US
Get TickerSpark's AI analysis on GNW
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.78B
- P/E
- 55.07
- Fwd P/E
- 6.84
- PEG
- -0.76
- P/S
- 0.42
- P/B
- 0.35
- EV/EBITDA
- 3.94
- Div Yield
- 0.00%
- Gross Margin
- 44.02%
- Op Margin
- 3.43%
- Net Margin
- 0.80%
- ROE
- 0.63%
- ROIC
- 0.36%
Latest fiscal year · YoY change
- Revenue
- $6.37B-10.9%
- Gross Profit
- $1.55B+177.1%
- Op Income
- $433.00M
- Net Income
- $223.00M-25.4%
- EPS
- $0.55-20.3%
- OCF Growth
- +271.6%
- FCF Growth
- +271.6%
- 52W High
- $10.69
- 52W Low
- $7.58
- 50D MA
- $9.15
- 200D MA
- $9.12
- Beta
- 0.86
- RSI (14)
- 21
- Avg Volume
- 3.87M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Genworth posted a quarterly net loss but highlighted strong Enact capital returns, continued share buybacks, and progress scaling CareScout, while also warning that the annual assumption review could be materially unfavorable.· November 5, 2026
- Net loss was $41 million, while adjusted operating income excluding the Closed Block was $102 million, supported by Enact's $132 million of adjusted operating income.
- Enact remained the main earnings and liquidity driver, contributing $122 million of capital returns to Genworth in the quarter and $485 million expected for full-year 2026 based on the updated outlook.
- CareScout Services generated $7 million of revenue in the quarter and is still expected to reach $25 million in revenue for 2026, though management said match volumes are pacing below the prior full-year match target.
- The Closed Block remained under pressure from adverse actual-versus-expected experience, including a $111 million pretax liability remeasurement loss, and management said the annual assumption review could be materially unfavorable.
- Capital return remained active: Genworth repurchased $80 million of shares in the quarter, another $40 million in October, and the board authorized an additional $500 million under the repurchase program.
Genworth reported a third-quarter net loss of $41 million and adjusted operating income, excluding the Closed Block, of $102 million. Enact contributed $132 million of adjusted operating income to Genworth, including a $37 million pretax reserve release that drove a 20% loss ratio; earned premiums were $242 million, new insurance written was $14.1 billion, primary insurance in force rose to $275 billion, and Enact's PMIERs sufficiency ratio was 158% with approximately $1.8 billion above requirements. The Closed Block reported an adjusted operating loss of $146 million, including a $111 million pretax liability remeasurement loss, and the company said A/E loss experience has trended above the prior full-year expectation of approximately $300 million. Holding company cash and liquid assets were $320 million, with about $200 million set aside for future obligations. For 2026, Enact now expects to return approximately $600 million of capital to shareholders, implying about $485 million to Genworth based on its roughly 81% stake; Genworth now expects to allocate between $275 million and $300 million to share repurchases. CareScout Services revenue was $7 million in the quarter and $19 million year-to-date, with a 2026 revenue target of $25 million, and the company expects CareScout Services investment of about $55 million in 2026.
Tom McInerney framed the quarter around three strategic priorities: using Enact's cash flows to create shareholder value, building CareScout into a scalable aging-care platform, and managing the Closed Block for long-term self-sustainability. His tone was confident and reflective, including an announcement that he will retire at the end of the year and hand leadership to Jerome Upton. He emphasized that Genworth is in a stronger position than when he arrived and said the company is positioned to drive sustainable long-term growth.
Jerome Upton said third-quarter results were driven by strong Enact performance, partially offset by losses in Corporate and Other and a $146 million adjusted operating loss in the Closed Block. He highlighted the $111 million pretax A/E loss in LTC, said early work on the annual assumption review suggests U.S. GAAP updates could be materially unfavorable in the aggregate, and noted that initial statutory testing indicates GLIC margins should remain positive. On liquidity and capital, he said holding company cash and liquid assets were $320 million, with about $200 million reserved for future obligations, repurchased $80 million of shares in the quarter and $40 million in October, and reduced holding company debt to $747 million after retiring $21 million of principal at a discount.
The main analyst question focused on the higher-than-normal $200 million of holding company cash reserved for future obligations. Jerome Upton said the increase was mainly due to taxes, including about $80 million tied to a tax refund and reserves set aside because the upcoming GLIC reinsurance restructure will create tax losses that the company expects to compensate at the subsidiary level. Ryan Krueger also asked about the AXA appeal timeline; Greg Karawan said there is no set deadline, but the best estimate is about 1 to 3 months for a response to the permission-to-appeal request.
The bull case is that Enact continues to generate strong earnings and capital returns, with a robust 158% PMIERs sufficiency ratio and updated 2026 capital return expectations of about $485 million to Genworth. CareScout is still expanding its network, distribution and product set, with management maintaining a $25 million revenue target for Services in 2026 and expressing confidence in the platform's long-term scalability.
The bear case is that the Closed Block remains pressured by adverse experience, and management explicitly warned the annual assumption review could be materially unfavorable, especially in LTC due to care inflation and utilization trends. CareScout match volumes are running below the pace needed to hit the previously disclosed full-year match target, and management acknowledged that scaling CareScout businesses to breakeven will take time.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 97.6%
- Shares Outstanding
- 366.21M
- Float Shares
- 357.53M
of shares held by institutions
377 13F filers
Buy/sell ratio 0.20. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for GNW, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 55.32M | ▼ 559.69K |
| Vanguard Group Inc | 43.96M | ▼ 1.77M |
| Dimensional Fund Advisors LP | 25.50M | ▼ 118.35K |
| Vanguard Portfolio Management LLC | 22.31M | ▲ 107.69K |
| Donald Smith & Co., Inc. | 20.00M | ▼ 2.48M |
| Vanguard Capital Management LLC | 17.03M | ▲ 424.19K |
| State Street Corp | 16.07M | ▼ 477.27K |
| Fmr LLC | 13.86M | ▲ 3.95M |
| River Road Asset Management, LLC | 13.35M | ▼ 1.12M |
| American Century Companies Inc | 11.46M | ▼ 78.23K |
| Nuveen, LLC | 11.46M | ▲ 276.29K |
| Geode Capital Management, LLC | 10.11M | ▼ 126.29K |
Held by 409 ETFs
Biggest fund positions in GNW by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 3, 26 | McInerney Thomas J | sell | 100,000 |
| Aug 24, 26 | Hagerman Melissa | sell | 14,708 |
| Aug 24, 26 | Hagerman Melissa | other | 11,000 |
| Aug 21, 26 | Karawan Gregory S. | sell | 40,000 |
| Jul 13, 26 | Shah Samir B. | other | 15,965 |
| Jul 13, 26 | Shah Samir B. | other | 8,160 |
| Jul 13, 26 | Shah Samir B. | other | 15,965 |
| May 27, 26 | McInerney Thomas J | other | 200,000 |
| May 22, 26 | McInerney Thomas J | sell | 100,000 |
| May 22, 26 | RESTREPO ROBERT P JR | sell | 50,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our GNW coverage
Recent articles, reports, and earnings notes.
No research on GNW yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GNW report →Genworth Financial, Inc. $GNW Shares Sold by Fifth Third Bancorp
defenseworld.net · Nov 19
Is Genworth Financial (GNW) a Great Value Stock Right Now?
zacks.com · Nov 9
What Genworth Financial (GNW) Said on Its Q3 Earnings Call
marketbeat.com · Nov 7
Genworth Financial, Inc. (GNW) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 5
Genworth Financial Announces Third Quarter 2026 Results
businesswire.com · Nov 4
Genworth Financial Announces Leadership Transition
businesswire.com · Oct 30
5 Low Price-to-Sales Stocks to Sharpen Your Investment Strategy
zacks.com · Oct 29
Should Value Investors Buy Genworth Financial (GNW) Stock?
zacks.com · Oct 22
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.